Influence of scan duration on the accuracy of β-amyloid PET with florbetaben in patients with Alzheimer’s disease and healthy volunteers
- 27 October 2012
- journal article
- research article
- Published by Springer Science and Business Media LLC in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 40 (2), 238-244
- https://doi.org/10.1007/s00259-012-2268-8
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Positron Emission Tomography Radiopharmaceuticals for Imaging Brain Beta-AmyloidSeminars in Nuclear Medicine, 2011
- Florbetapir F-18: A Histopathologically Validated Beta-Amyloid Positron Emission Tomography Imaging AgentSeminars in Nuclear Medicine, 2011
- Individualized quantification of brain β-amyloid burden: results of a proof of mechanism phase 0 florbetaben PET trial in patients with Alzheimer’s disease and healthy controlsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2011
- Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic studyThe Lancet Neurology, 2011
- Visual assessment of [11C]PIB PET in patients with cognitive impairmentEuropean Journal of Nuclear Medicine and Molecular Imaging, 2010
- Amyloid-plaque imaging in early and differential diagnosis of dementiaAnnals of Nuclear Medicine, 2010
- Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject BrainNeuroImage, 2002
- The molecular pathology of Alzheimer's diseaseNeuron, 1991
- The validity of 3 clinical diagnostic criteria for Alzheimer's diseaseNeurology, 1990
- Clinicopathological analysis of dementia disorders in the elderlyJournal of the Neurological Sciences, 1990